2023

Home ▶ Washington Letter ▶ Washington Letter ▶ RESEARCH
RESEARCH

Senate Makes Progress on Funding Bills, House Struggles with Funding Measures
Last week, the Senate Appropriations Committee approved its version of the Fiscal Year 2024 Labor, Health and Human Services, Education and Related Agencies spending bill. Below are funding levels for key federal programs of interest to ATS members:
 
National Institutes of Health 

The bill provides $47.7 billion for the National Institutes of Health:
 

  • $7.38 billion for the National Cancer Institute, a proposed increase of $60 million over FY 2023. 
  • $3.98 billion for the National Heart, Lung, and Blood Institute level funded with FY 2023. 
  • $6.56 billion for the National Institute of Allergy and Infectious Disease, level funded with FY 2023. 
  • $1.76 billion for the National Institute of Child Health and Human Development, a proposed increase of $10 million over FY 2023. 
  • $913.98 million for the National Institute of Environmental Health Sciences, level funded with FY 2023. 
  • $197.69 million for the National Institute of Nursing Research, level funded with FY 2023.
  • $525.4 million for the National Institute on Minority Health and Health Disparities, level funded with FY 2023. 
  • $2.83 billion for the Office of the Director, a proposed increase of $179 million over FY 2023, including $722.4 million for the Common Fund, level funded with FY 2023. 
ARPA-H

The committee’s bill would provide $1.5 billion in new funding for ARPA-H, available through September 30, 2026, in addition to funding provided and available to ARPA-H to date.

Centers for Disease Control and Prevention 

In addition, the bill includes $9.2 billion for the Centers for Disease Control and Prevention, an increase of $20 million.

IMMUNIZATION AND RESPIRATORY DISEASES 
 
  • $919.29 million for Immunization and Respiratory Diseases, level funded with FY 2023. 

HIV/AIDS, VIRAL HEPATITIS, SEXUALLY TRANSMITTED DISEASES AND TUBERCULOSIS PREVENTION 
 
  • $1.40 billion for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, an increase of $4 million over FY 2023. 
  • $137.03 million for Tuberculosis, level funded with FY 2023. 

EMERGING AND ZOONOTIC INFECTIOUS DISEASES 
 
  • $750.72 million for Emerging and Zoonotic Infectious Diseases, level funded with FY 2023. 
  • $197 million for the Antibiotic Resistance Initiative, level funded with FY 2023.  
CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION
  • $1.44 billion for Chronic Disease Prevention and Health Promotion, a proposed increase of $5 million over FY 2023. 
  • $246.5 million for Tobacco, level funded with FY 2023. 
  • $4.5 million for the Chronic Disease Education and Awareness Program, level funded with FY 2023.  
  • $725,000 for the Cancer Survivorship Resource Center, level funded with FY 2023. 
  • $68.95 million for the Racial and Ethnic Approach to Community Health (REACH) program, level funded with FY 2023. 
  • $8 million for social determinants of health, level funded with FY 2023.  
ENVIRONMENTAL HEALTH 
 
  • $246.85 million for Environmental Health, level funded with FY 2023 
  • $10 million for Climate and Health, level funded with FY 2023. 
  • $33.5 million for Asthma, level funded with FY 2023. 

INJURY PREVENTION AND CONTROL 
 
  • $761.88 million for Injury Prevention and Control, a proposed increase of $0.5 million over FY 2023. 

OCCUPATIONAL SAFETY AND HEALTH 
 
  • $362.8 million for Occupational Safety and Health, level funded with FY 2023.  
  • $1.2 million for the National Mesothelioma Registry and Tissue Bank, level funded with FY 2023. 

GLOBAL HEALTH 
 
  • $692.84 million for Global Health, level funded at FY 2023. 
  • $11.72 million for Global Tuberculosis, level funded with FY 2023. 

By contrast the House of Representatives is struggling to move funding bills forward.  The Republican lead House Appropriations Committee has proposed bills with steeper cuts than negotiated in the budget agreement with the Biden Administration.  Draft bills released by the Appropriations Subcommittee Chair include cuts to NIH, CDC, EPA and other public health program funding.

The proposed cuts in the House measures have led to significant opposition to the funding measures from both Democrats and centrist Republicans, delaying the House appropriations process and potentially setting the stage for a government shut down later this year.

The ATS has been in touch with appropriators in both the House and Senate and has urged them to provide increases to key research, public health and environmental programs.
Last Reviewed: September 2023